Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
A Cell-Specific Death Program Claims Motoneurons
12 September 2002. It appears that a particular cell-death pathway can be restricted to one class of neurons, suggesting a mechanism for the specificity of neuronal death in diseases ranging from ALS to Alzheimer's. In today’s Neuron, Christopher Henderson, Cedric Raoul, and colleagues at INSERM in Marseille, France, the University of Alabama at Birmingham, and the University of California, San Diego, investigate the hypothesis that the selective death of motoneurons in amytrophic lateral sclerosis could depend on the triggering of a Fas-related pathway.

Fas is a so-called "death receptor," linked to an intracellular caspase cascade ending in cell death. The researchers found a novel pathway linked to the Fas receptor in embryonic mouse motoneurons. Its key step is the transcriptional regulation of neuronal nitric oxide synthase by a cascade involving, in sequence, the Fas-associated protein Daxx; apoptosis signal-regulating kinase 1(ASK1); and p38 kinase. Working in concert with the classic Fas cascade, activation of the novel pathway can trigger cell death. However, there was no evidence for this pathway in other cell types reported to be responsive to Fas (fibroblasts, thymocytes, embryonic cortical neurons).

Henderson et al. then cultured motoneurons from three different transgenic ALS mouse models. These mice carry some of the identified defects in the gene for superoxide dismutase 1 (SOD1), which have been linked to about twenty percent of familial ALS cases. The SOD1 transgenic neurons were highly vulnerable to exogenous Fas agonists and NO. As evidence that this vulnerability was not a function of the in-vitro system, the researchers demonstrated that other SOD1 mouse cells were not any more vulnerable to trophic deprivation or excitotoxic stimulation than were wild-type neurons or other types of control cells from brain or other tissues.
"The model we have illustrated here for the specific case of motoneurons and mouse models of ALS may be more generally applicable: neuronal class-specific pathways for degeneration or death, potentially sensitized by genetic or environmental factors," the authors write.

This may be highly significant for identifying viable therapies, Zhi-Qi Xiong and Jim McNamara of Duke University in Durham, North Carolina, point out in an accompanying editorial. "Because apoptosis is also critical to diverse physiological processes, nonselective anti-apoptotic agents have practical limitations (Nicholson et al. 2000). The finding of a cell type-specific apoptosis pathway provides new molecular targets by which apoptosis in a specific cell type might be selectively modulated without adverse effects on other systems," they write. -Hakon Heimer

Reference:Raoul C, Estevez AG, Nishimune H, Cleveland DW, deLapeyriere O, Henderson CE, Haase G, Pettmenn B. Motoneuron death triggered by a specific pathway downstream of Fas: Potentiation by ALS-linked SOD1 mutations. Neuron. 12 Sep 2002;35:1067-83. (Abstract)

Xiong Z-Q, McNamara JO. Fas(t) balls and Lou Gehrig disease: A clue to selective vulnerability of motor neurons. Neuron. 12 Sep 2002;35:1011-4. (Abstract)

 
Comments on News and Primary Papers
  Primary Papers: Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.

Comment by:  Eddie Koo, ARF Advisor
Submitted 12 October 2002  |  Permalink Posted 12 October 2002
  I recommend this paper

A potential explanation for selective vulnerability of motoneurons in ALS. Whether the motoneurons cultured from embryos can be extended to other neurons in the body is unclear. The curious sparing of oculomotor neurons remains a big mystery to me.

View all comments by Eddie Koo
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad